Back to Search
HARRIET KLUGER, MD
MD
Medical Oncology Physician
NPI: 1528042819IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
038926(CT)
Education
OTHER
Class of 1993
Research & Publications (20)
Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells.
PMID 18626467·Lab Invest·2008
8-other
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
PMID 17257402·J Transl Med·2007
8-other
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
PMID 15994930·Cancer Res·2005
7-preclinical
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
PMID 14734466·Clin Cancer Res·2004
8-other
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model.
PMID 14767486·Lab Invest·2004
7-preclinical
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.
PMID 15179190·Melanoma Res·2004
8-other
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
PMID 19188183·Clin Cancer Res·2009
3-trial
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
PMID 19383818·Clin Cancer Res·2009
8-other
Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.
PMID 19151756·Oncogene·2009
8-other
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
PMID 18552823·Mod Pathol·2008
8-other
Suppressor role of activating transcription factor 2 (ATF2) in skin cancer.
PMID 18227516·Proc Natl Acad Sci U S A·2008
7-preclinical
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
PMID 18628459·Clin Cancer Res·2008
8-other
Assessing expression of apoptotic markers using large cohort tissue microarrays.
PMID 18175814·Methods Mol Biol·2008
6-review
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
PMID 18430249·Breast Cancer Res·2008
8-other
High HSP90 expression is associated with decreased survival in breast cancer.
PMID 17409397·Cancer Res·2007
7-preclinical
Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
PMID 17804730·Cancer Res·2007
8-other
Characterizing disease states from topological properties of transcriptional regulatory networks.
PMID 16670008·BMC Bioinformatics·2006
8-other
Rab33A: characterization, expression, and suppression by epigenetic modification.
PMID 16810302·J Invest Dermatol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 HOWARD AVE, YALE PHYSICIANS BUILDING - 2ND FLOOR
NEW HAVEN, CT 06519 - Phone
- (203) 688-4191
Quick Facts
- NPI
- 1528042819
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile